Biological properties of D- and L-1-deoxyazasugars

Journal of Medicinal Chemistry

Volumn 48, Issue 6, 2005, Pages 2036-2044

  Kato, Atsushi ^a   Kato, Noriko ^a   Kano, Erika ^a   Adachi, Isao ^a   Ikeda, Kyoko ^b   Yu, Liang ^b   Okamoto, Tadashi ^c   Banba, Yasunori ^a   Ouchi, Hidekazu ^d   Takahata, Hiroki ^d   Asano, Naoki ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b HOKURIKU UNIVERSITY   (Japan)

^c KOBE GAKUIN UNIVERSITY   (Japan)

^d TOHOKU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1 DEOXYALLONOJIRIMYCIN; 1 DEOXYALTRONOJIRIMYCIN; 1 DEOXYGALACTONOJIRIMYCIN; 1 DEOXYGULUNOJIRIMYCIN; 1 DEOXYMANNONOJIRIMYCIN; 1 DEOXYNOJIRIMYCIN; ALPHA GALACTOSIDASE; ALPHA GLUCOSIDASE; ALPHA LEVO FUCOSIDASE; ALPHA MANNOSIDASE; GLYCOSIDASE INHIBITOR; UNCLASSIFIED DRUG;

ARTICLE; DRUG DESIGN; DRUG HYDROLYSIS; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; ENANTIOSELECTIVITY; ENZYME INHIBITION; FABRY DISEASE; LYSOSOME STORAGE DISEASE; MANNOSIDOSIS; STRUCTURE ACTIVITY RELATION;

1-DEOXYNOJIRIMYCIN; ALPHA-GALACTOSIDASE; ALPHA-L-FUCOSIDASE; ALPHA-MANNOSIDASE; ANIMALS; BETA-GALACTOSIDASE; BETA-GLUCOSIDASE; BETA-MANNOSIDASE; CATTLE; ENZYME INHIBITORS; GLUCAN 1,4-ALPHA-GLUCOSIDASE; HUMANS; LYSOSOMES; MALE; MOLECULAR MIMICRY; RATS; SPECIES SPECIFICITY; STEREOISOMERISM; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 20144382745     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm0495881     Document Type: Article

References (58)

1. Iminosugars as Glycosidase Inhibitors: Nojirimycin and Beyond; Stütz, A. E., Ed.; Wiley-VCH: Weinheim, 1999.
2. Asano, N.; Nash, R. J.; Molyneux, R. J.; Fleet, G. W. J. Sugar-mimic glycosidase inhibitors: natural occurrence, biological activity and prospects for therapeutic application. Tetrahedron Asymmetry 2000, 11, 1645-1680.
3. Watson, A. A.; Fleet, G. W. J.; Asano, N.; Molyneux, R. J.; Nash, R. J. Polyhydroxylated alkaloids-natural occurrence and therapeutic applications. Phytochemistry 2001, 56, 265-295.
4. Martin, O. R., Compain, P., Eds. Iminosugars: Recent Insights into their Bioactivity and Potential as Therapeutic Agents. Curr. Top. Med. Chem. 2003, 3 (5).
5. Asano, N. Glycosidase inhibitors: update and perspectives on practical use. Glycobiology 2003, 13, 93R-104R.
6. Mitrakou, A.; Tountas, N.; Raptis, A. E.; Bauer, R. J.; Schulz, H.; Raptis, S. A. Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. Diab. Med. 1998, 15, 657-660.
7. Butters, T. D.; Dwek, R. A.; Platt, F. M. Therapeutic applications of imino sugars in lysosomal storage disorders. Curr. Top. Med. Chem. 2003, 3, 561-574.
8. Butters, T. D.; Dwek, A.; Platt, F. M. Inhibition of glycosphingolipid biosynthesis: application to lysosomal storage disorders. Chem. Rev. 2000, 100, 4683-4696.
9. Cox, T.; Lachmann, R.; Hollak, C.; Aerts, J.; van Weely, S.; Hrebicek, M.; Platt, F. M.; Butters, T. D.; Dwek, R.; Moyses, C.; Gow, I.; Elstein, D.; Zimran, A. Novel oral treatment of Gaucher's disease with N- butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 2000, 355, 1481-1485.
10. Fan, J.-Q.; Ishii, S.; Asano, N.; Suzuki, Y. Accelerated transport and maturation of lysosomal α-galactosidase A in Fabry lymphoblasts by an enzyme inhibitor. Nat. Med. 1909, 5, 112-115.
11. Asano, N.; Ishii, S.; Kizu, H.; Ikeda, K.; Yasuda, K.; Kato, A.; Martin, O. R.; Fan, J.-Q. In vitro inhibition and intracellular enhancement of lysosomal α-galactosidase A activity in Fabry lymphoblasts by 1- deoxygalactonojirimycin and its derivatives. Eur. J. Biochem. 2000, 267, 4179-4186.
12. Sawkar, A. R.; Cheng, W.-C.; Beutler, E.; Wong, C.-H.; Balch, W. E.; Kelly, J. W. Chemical chaperones increase the cellular activity of N370S β-glucosidase: a therapeutic strategy for Gaucher disease. Proc. Natl. Acad. Sci. U.S.A. 2002, 99, 15428-15433.
13. M1-gangliosidosis. Proc. Natl. Acad. Sci. U.S.A. 2003, 100, 15912-15917.
14. Welch, W. J.; Brown, C. R. Influence of molecular and chemical chaperones on protein folding. Cell Stress Chaperones 1996, 1, 109-115.
15. Fan, J.-Q. A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity. Trends Pharmacol. Sci. 2003, 24, 355-360.
16. Yamashita, T.; Yasuda, K.; Kizu, H.; Kameda, Y.; Watson, A. A.; Nash, R. J.; Fleet, G. W. J.; Asano, N. New polyhydroxylated pyrrolidines, piperidine, and pyrrolizidine alkaloids from Scilla sibirica. J. Nat. Prod. 2002, 65, 1875-1881.
17. Asano, N.; Yasuda, K.; Kizu, H.; Kato, A.; Fan, J.-Q.; Nash, R. J.; Fleet, G. W. J.; Molyneux, R. J. Novel α-L-fucosidase inhibitors from the bark of Angylocalyx pynaertii (Leguminosae). Eur. J. Biochem. 2001, 268, 35-41.
18. Winchester, B.; Fleet, G. W. J. Modification of glycosylation as a therapeutic strategy. J. Carbohydr. Chem. 2000, 19, 471-483.
19. Asano, N.; Hashimoto, H. Azaglycomimetics: synthesis and chemical biology. Glycoscience: Chemistry and Chemical Biology III; Fraser-Reid, B. O., Tatsuta, K., Thiem, J., Eds.; Springer-Verlag: Berlin, Heidelberg, 2001; pp 2541-2594.
20. Elbein, A. D. Inhibitors of the biosynthesis and processing of N-linked oligosaccharide chains. Annu. Rev. Biochem. 1987, 56, 497-534.
21. Elbein, A. D. Glycosidase inhibitors: inhibitors of N-linked oligosaccharide processing. FASEB J. 1991, 5, 3055-3063.
22. Winchester, B.; Fleet, G. W. J. Amino-sugar glycosidase inhibitors: versatile tools for glycobiologists. Glycobiology 1992, 2, 199-210.
23. Takahata, H.; Banba, Y.; Ouchi, H.; Nemoto, H. Concise and highly stereocontrolled synthesis of 1-deoxygalactonojirimycin and its congeners using dioxanylpiperidene, a promising chiral building block. Org. Lett. 2003, 5, 2527-2529.
24. Dondoni, A.; Perrome, D. Synthesis of 1,1-dimethylethyl (S)-4-formyl-2,2-dimethyl-3-oxazolidinecarboxylate by oxidation of the alcohol. Org. Synth. 1999, 77, 64-77.
25. Garner, P.; Park, J. M.; Malecki, E. A stereodivergent synthesis of D-erythro-sphingosine and D-threo-sphingosine from L-serine. J. Org. Chem. 1988, 53, 4395-4398.
26. Herold, P. Synthesis of D-erythro- and D-threo-sphingosine derivatives from L-serine. Helv. Chim. Acta 1988, 71, 354-363.
27. Grubbs, R. H.; Chang, S. Recent advances on olefin metathesis and its application in organic synthesis. Tetrahedron 1998, 54, 4413-4450.
28. Takahata, H.; Banba, Y.; Sasatani, M.; Nemoto, H.; Kato, A.; Adachi, I. Asymmetric synthesis of 1-deoxynojirimycin and its congeners from a common chiral building block. Tetrahedron 2004, 60, 8199-8205.
29. Asano, N.; Yamashita, T.; Yasuda, K.; Ikeda, K.; Kizu, H., Kameda, Y.; Kato, A.; Nash, R. J.; Lee, H.-S.; Ryu, K.-S. Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.). J. Agric. Food Chem. 2001, 49, 4208-4213.
30. Yasuda, K.; Kizu, H.; Yamashita, T.; Kameda, Y.; Kato, A.; Nash, R. J.; Fleet, G. W. J.; Molyneux, R. J.; Asano, N. New sugar-mimic alkaloids from the pods of Angylocalyx pynaertii. J. Nat. Prod. 2002, 65, 198-202.
31. Schmidt, D. D.; Frommer, W.; Muller, L.; Tusheit, E. Glucosidase- inhibitoren aus Bazillen. Naturwissenschaften 1979, 66, 584-585.
32. Evans, S. V.; Fellows, L. E.; Shing, T. K. M.; Fleet, G. W. J. Glycosidase inhibition by plant alkaloids which are structural analogues of monosaccharides. Phytochemistry 1985, 24, 1953-1955.
33. Fuhrmann, U.; Bause, E.; Ploegh, H. Inhibitors of oligosaccharide processing. Biochim. Biophys. Acta 1985, 825, 95-110.
34. Scofield, A. M.; Fellows, L. E.; Nash, R. J.; Fleet, G. W. J. Inhibition of mammalian digestive disaccharidases by polyhydroxy alkaloids. Life Sci. 1886, 39, 645-650.
35. Asano, N.; Oseki, K.; Kizu, H.; Matsui, K. Nitrogen-in-the-ring pyranose and furanoses: structural basis of inhibition of mammalian glycosidases. J. Med. Chem. 1994, 37, 3701-3706.
36. Legler, G.; Pohl, S. Synthesis of 5-amino-5-deoxy-D-galactopyranose and 1,5-dideoxy-1,5-imino-D-galactitol, and their inhibition of α- and β-D-galactosidase. Carbohydr. Res. 1986, 155, 119-129.
37. Zhou, P.; Salleh, H. M.; Chan, P. C. M.; Lajoie, G.; Honek, J. F.; Nambiar, P. T. C.; Ward, O. P. A chemoenzymic synthesis of 1,5-dideoxy-1,5- imino-L-mannitol and -L-rhamnitol and investigation of their effects on glycosidases. Carbohydr. Res. 1993, 155-166.
38. Fleet, G. W. J.; Shaw, A. N.; Evans, S. V.; Fellows, L. E. Synthesis from D-glucose of 1,5-dideoxy-1,5-imino-L-fucitol, a potent α-L-fucosidase inhibitor. J. Chem. Soc., Chem. Commun. 1985, 841-842.
39. Fleet, G. W. J.; Namgoong, S. K.; Barker, C.; Baines, S.; Jacob, G. S.; Winchester, B. Iminoheptitols as glycosidase inhibitors: synthesis and specific α-L-fucosidase inhibition by β-L-homofuconojirimycin and 1-β-C-substituted deoxymannojirimycin. Tetrahedron Lett. 1989, 30, 4439-4442.
40. Winchester, B.; Barker, C.; Baines, S.; Jacob, G. S.; Namgoong, S. K.; Fleet, G. W. J. Inhibition of α-L-fucosidase by derivatives of deoxyfuconojirimycin and deoxymannojirimycin. Biochem. J. 1990, 265, 277-282.
41. Asano, N.; Nishida, M.; Kato, A.; Kizu, H.; Matsui, K.; Shimada, Y.; Itoh, T.; Baba, M.; Watson, A. A.; Nash, R. J.; de Lilley, P. M. Q.; Watkin, D. J.; Fleet, G. W. J. Homonojirimycin isomers and N-alkylated homonojirimycins: structural and conformational basis of inhibition of glycosidases. J. Med. Chem. 1998, 41, 2565-2571.
42. Hurtley, S. M.; Helenius, A. A protein oligomerization in the endoplasmic reticulum. Annu. Rev. Cell Biol. 1989, 5, 277-307.
43. Gething, M.-J.; Sambrook, J. Protein folding in the cells. Nature 1992, 355, 33-45.
44. Helenius, A.; Marquardt, T.; Braakmann, I. The endoplasmic reticulum as a protein folding compartment. Trends Cell Biol. 1992, 2, 227-231.
45. Bychova, V. E.; Ptitsyn, O. B. Folding intermediates are involved in genetic diseases? FEBS Lett. 1995, 359, 6-8.
46. Welch, W. J.; Brown, C. R. Influence of molecular and chemical chaperones on protein folding. Cell Stress Cap. 1996, 1, 109-115.
47. Remeo, G.; Urso, M.; Piszcane, Ablum, E.; de Falco, A.; Ruffilli, A. Residual activity of α-galactosidase A in Fabry's disease. Biochem. Genet. 1975, 13, 615-628.
48. Ishii, S.; Kase, R.; Okumiya, T.; Sakuraba, H.; Suzuki, Y. Aggregation of the inactive form of human α-galactosidase in the endoplasmic reticulum. Biochem. Biophys. Res. Commun. 1996, 220, 812-815.
49. Lodish, H. F.; Kong, N. Glucose removal from N-linked oligosaccharides is required for efficient maturation of certain secretory glycoproteins from the rough endoplasmic reticulum to the Golgi complex. J. Cell Biol. 1984, 98, 1720-1729.
50. Tominaga, L.; Ogawa, Y.; Taniguchi, M.; Ohno, K.; Matsuda, J.; Oshima, A.; Suzuki, Y.; Nanba, E. Galactonojirimycin derivatives restore mutant human β-galactosidase activities expressed in fibroblasts from enzyme-deficient knockout mouse. Brain Dev. 2001, 23, 284-287.
51. Moremen, K. W.; Trimble, A.; Herscovics, A. Glycosidases of the asparagines-linked oligosaccharide processing pathway. Glycobiology 1994, 4, 113-125.
52. Daniel, P. F.; Winchester, B.; Warren, C. D. Mammalian α-mannosidases: multiple forms but a common purpose? Glycobiology 1904, 4, 551-566.
53. Vallée, F.; Karaveg, K.; Herscovics, A.; Moremen, K. W. Howell, P. L. Structural basis for catalysis and inhibition of N-glycan processing class I α1,2-mannosidases. J. Biol. Chem. 2000, 275, 41287-41298.
54. Chotai, K.; Jennings, C.; Winchester, B.; Dorling, P. The uptake of swainsonine, a specific inhibitor of α-mannosidase, into normal human fibroblasts in culture. J. Cell Biochem. 1983, 21, 107-117.
55. Ikeda, K.; Kato, A.; Adachi, I.; Haraguchi, M.; Asano, N. Alkaloids from the poisonous plant Ipomoea carnea: effects on intracellular lysosomal glycosidase activities in human lymphoblast cultures. J. Agric. Food Chem. 2003, 51, 7642-7646.
56. Skudlarek, M. D.; Tulsiani, D. R. P.; Orgebin-Crist, M.-C. Rat epididymal luminal fluid acid β-D-galactosidase optimally hydrolyses glycoprotein substrate at neutral pH. Biochem. J. 1992, 286, 907-914.
57. Kessler, M.; Acuto, O.; Strelli, C.; Murer, H.; Semenza, G. A. A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport system. Biochim. Biophys. Acta 1978, 506, 136-154.
58. Ishii, S.; Kase, R.; Sakuraba, H.; Fujita, S.; Sugimoto, M.; Tomita, K.; Semba, T.; Suzuki, Y. Human α-galactosidase gene expression: significance of two peptide regions encoded by exons 1-2 and 6. Biochim. Biophys. Acta 1994, 1204, 265-270.